rs61752346
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_198129.4(LAMA3):c.8851C>T(p.Arg2951Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00247 in 1,614,022 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2951H) has been classified as Uncertain significance.
Frequency
Consequence
NM_198129.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LAMA3 | NM_198129.4 | c.8851C>T | p.Arg2951Cys | missense_variant | 67/75 | ENST00000313654.14 | |
LAMA3 | NM_000227.6 | c.4024C>T | p.Arg1342Cys | missense_variant | 30/38 | ENST00000269217.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LAMA3 | ENST00000313654.14 | c.8851C>T | p.Arg2951Cys | missense_variant | 67/75 | 1 | NM_198129.4 | P1 | |
LAMA3 | ENST00000269217.11 | c.4024C>T | p.Arg1342Cys | missense_variant | 30/38 | 1 | NM_000227.6 |
Frequencies
GnomAD3 genomes AF: 0.00140 AC: 213AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00104 AC: 261AN: 251434Hom.: 0 AF XY: 0.00107 AC XY: 146AN XY: 135890
GnomAD4 exome AF: 0.00258 AC: 3766AN: 1461742Hom.: 10 Cov.: 32 AF XY: 0.00242 AC XY: 1761AN XY: 727178
GnomAD4 genome AF: 0.00140 AC: 213AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.00110 AC XY: 82AN XY: 74474
ClinVar
Submissions by phenotype
Junctional epidermolysis bullosa gravis of Herlitz Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Jan 05, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 07, 2022 | Variant summary: LAMA3 c.4024C>T (p.Arg1342Cys) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.001 in 251434 control chromosomes. The observed variant frequency is approximately 1.2 fold of the estimated maximal expected allele frequency for a pathogenic variant in LAMA3 causing Junctional Epidermolysis Bullosa phenotype (0.00087), strongly suggesting that the variant is benign. c.4024C>T has been reported in the literature as R1331C in at-least one individual affected with a mild clinical manifestation of Junctional Epidermolysis Bullosa with normal hemidesmosome by electron microscopy and normal Laminin 5 staining by immunofluorescence (example, Nakano_2002). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly benign. - |
Laryngo-onycho-cutaneous syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at